CORCEPT THERAPEUTICS INC Increase (Decrease) in Other Accrued Liabilities
CORCEPT THERAPEUTICS INC (CORT) reported Increase (Decrease) in Other Accrued Liabilities of $24.94 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherAccruedLiabilities · last filed 2026-07-29
- CORCEPT THERAPEUTICS INC increase (decrease) in other accrued liabilities for the quarter ending 2026-06-30 was $34.31M, a 380.67% increase year-over-year.
- CORCEPT THERAPEUTICS INC increase (decrease) in other accrued liabilities for the quarter ending 2026-03-31 was -$9.38M.
- CORCEPT THERAPEUTICS INC increase (decrease) in other accrued liabilities for the quarter ending 2025-12-31 was -$13.24M, a 223.57% decline year-over-year.
- CORCEPT THERAPEUTICS INC increase (decrease) in other accrued liabilities for the quarter ending 2025-09-30 was $15.90M, a 19.00% decline year-over-year.
- CORCEPT THERAPEUTICS INC increase (decrease) in other accrued liabilities for fiscal 2025 was $3.93M, a 89.73% decline from fiscal 2024.
- CORCEPT THERAPEUTICS INC increase (decrease) in other accrued liabilities for fiscal 2024 was $38.24M, a 116.68% increase from fiscal 2023.
- CORCEPT THERAPEUTICS INC increase (decrease) in other accrued liabilities for fiscal 2023 was $17.65M, a 502.97% increase from fiscal 2022.
- CORCEPT THERAPEUTICS INC increase (decrease) in other accrued liabilities for fiscal 2022 was $2.93M, a 54.82% decline from fiscal 2021.
| Period end | Increase (Decrease) in Other Accrued Liabilities 3 month | Increase (Decrease) in Other Accrued Liabilities 3 month as first filed | Increase (Decrease) in Other Accrued Liabilities 6 month | Increase (Decrease) in Other Accrued Liabilities 6 month as first filed | Increase (Decrease) in Other Accrued Liabilities 9 month | Increase (Decrease) in Other Accrued Liabilities 9 month as first filed | Increase (Decrease) in Other Accrued Liabilities 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $34.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $24.94M 10-Q · filed 2026-07-29 | $11.70M derived: sum of 3 quarters · filed 2026-07-29 | $27.60M derived: sum of 4 quarters · filed 2026-07-29 | |||
| 2026-03-31 | -$9.38M 10-Q · filed 2026-04-30 | -$22.61M derived: sum of 2 quarters · filed 2026-04-30 | -$6.72M derived: sum of 3 quarters · filed 2026-04-30 | $422.00K derived: sum of 4 quarters · filed 2026-07-29 | |||
| 2025-12-31 | -$13.24M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $2.66M derived: sum of 2 quarters · filed 2026-02-24 | $9.80M derived: sum of 3 quarters · filed 2026-07-29 | $3.93M 10-K · filed 2026-02-24 | |||
| 2025-09-30 | $15.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $23.04M derived: sum of 2 quarters · filed 2026-07-29 | $17.16M 10-Q · filed 2025-11-04 | $27.88M derived: sum of 4 quarters · filed 2026-07-29 | |||
| 2025-06-30 | $7.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $1.27M 10-Q · filed 2026-07-29 | $6.00K 10-Q · filed 2025-07-31 | $11.98M derived: sum of 3 quarters · filed 2026-07-29 | $31.60M derived: sum of 4 quarters · filed 2026-07-29 | ||
| 2025-03-31 | -$5.87M 10-Q · filed 2026-04-30 | -$5.94M 10-Q · filed 2025-05-05 | $4.84M derived: sum of 2 quarters · filed 2026-04-30 | $24.46M derived: sum of 3 quarters · filed 2026-04-30 | $23.26M derived: sum of 4 quarters · filed 2026-04-30 | ||
| 2024-12-31 | $10.71M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $30.34M derived: sum of 2 quarters · filed 2026-02-24 | $29.13M derived: sum of 3 quarters · filed 2026-02-24 | $38.24M 10-K · filed 2026-02-24 | |||
| 2024-09-30 | $19.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $18.42M derived: sum of 2 quarters · filed 2025-11-04 | $27.53M 10-Q · filed 2025-11-04 | $8.48M derived: sum of 4 quarters · filed 2026-02-24 | |||
| 2024-06-30 | -$1.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $7.91M 10-Q · filed 2025-07-31 | -$11.14M derived: sum of 3 quarters · filed 2026-02-24 | $6.28M derived: sum of 4 quarters · filed 2026-02-24 | |||
| 2024-03-31 | $9.11M 10-Q · filed 2025-05-05 | -$9.93M derived: sum of 2 quarters · filed 2026-02-24 | $7.48M derived: sum of 3 quarters · filed 2026-02-24 | $18.74M derived: sum of 4 quarters · filed 2026-02-24 | |||
| 2023-12-31 | -$19.05M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$1.63M derived: sum of 2 quarters · filed 2026-02-24 | $9.62M derived: sum of 3 quarters · filed 2026-02-24 | $17.65M 10-K · filed 2026-02-24 | |||
| 2023-09-30 | $17.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | $28.67M derived: sum of 2 quarters · filed 2024-10-30 | $36.70M 10-Q · filed 2024-10-30 | $37.88M derived: sum of 4 quarters · filed 2025-02-26 | |||
| 2023-06-30 | $11.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-29 | $19.28M 10-Q · filed 2024-07-29 | $20.46M derived: sum of 3 quarters · filed 2025-02-26 | $25.13M derived: sum of 4 quarters · filed 2025-02-26 | |||
| 2023-03-31 | $8.03M 10-Q · filed 2024-05-01 | $9.21M derived: sum of 2 quarters · filed 2025-02-26 | $13.88M derived: sum of 3 quarters · filed 2025-02-26 | $5.96M derived: sum of 4 quarters · filed 2025-02-26 | |||
| 2022-12-31 | $1.18M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $5.85M derived: sum of 2 quarters · filed 2025-02-26 | -$2.07M derived: sum of 3 quarters · filed 2025-02-26 | $2.93M 10-K · filed 2025-02-26 | |||
| 2022-09-30 | $4.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | -$3.25M derived: sum of 2 quarters · filed 2023-11-01 | $1.75M 10-Q · filed 2023-11-01 | $5.10M derived: sum of 4 quarters · filed 2024-02-15 | |||
| 2022-06-30 | -$7.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | -$2.92M 10-Q · filed 2023-08-02 | $435.00K derived: sum of 3 quarters · filed 2024-02-15 | $3.23M derived: sum of 4 quarters · filed 2024-02-15 | |||
| 2022-03-31 | $5.00M 10-Q · filed 2023-05-03 | $8.35M derived: sum of 2 quarters · filed 2024-02-15 | $11.15M derived: sum of 3 quarters · filed 2024-02-15 | $14.69M derived: sum of 4 quarters · filed 2024-02-15 | |||
| 2021-12-31 | $3.36M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | $6.15M derived: sum of 2 quarters · filed 2024-02-15 | $9.70M derived: sum of 3 quarters · filed 2024-02-15 | $6.48M 10-K · filed 2024-02-15 | |||
| 2021-09-30 | $2.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $6.34M derived: sum of 2 quarters · filed 2022-11-03 | $3.12M 10-Q · filed 2022-11-03 | $3.14M 10-Q · filed 2021-11-03 | $5.36M derived: sum of 4 quarters · filed 2023-02-28 | ||
| 2021-06-30 | $3.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $328.00K 10-Q · filed 2022-08-04 | $333.00K 10-Q · filed 2021-07-29 | $2.56M derived: sum of 3 quarters · filed 2023-02-28 | -$1.13M derived: sum of 4 quarters · filed 2023-02-28 | ||
| 2021-03-31 | -$3.22M 10-Q · filed 2022-05-05 | -$985.00K derived: sum of 2 quarters · filed 2023-02-28 | -$4.67M derived: sum of 3 quarters · filed 2023-02-28 | -$1.62M derived: sum of 4 quarters · filed 2023-02-28 | |||
| 2020-12-31 | $2.23M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$1.46M derived: sum of 2 quarters · filed 2023-02-28 | $1.59M derived: sum of 3 quarters · filed 2023-02-28 | -$2.08M 10-K · filed 2023-02-28 | |||
| 2020-09-30 | -$3.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | -$639.00K derived: sum of 2 quarters · filed 2021-11-03 | -$4.32M 10-Q · filed 2021-11-03 | -$2.63M derived: sum of 4 quarters · filed 2022-02-15 | |||
| 2020-06-30 | $3.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | -$628.00K 10-Q · filed 2021-07-29 | $1.06M derived: sum of 3 quarters · filed 2022-02-15 | $6.20M derived: sum of 4 quarters · filed 2022-02-15 | |||
| 2020-03-31 | -$3.68M 10-Q · filed 2021-05-06 | -$1.99M derived: sum of 2 quarters · filed 2022-02-15 | $3.16M derived: sum of 3 quarters · filed 2022-02-15 | $763.00K derived: sum of 4 quarters · filed 2022-02-15 | |||
| 2019-12-31 | $1.69M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | $6.83M derived: sum of 2 quarters · filed 2022-02-15 | $4.44M derived: sum of 3 quarters · filed 2022-02-15 | -$517.00K 10-K · filed 2022-02-15 | |||
| 2019-09-30 | $5.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-03 | $2.75M derived: sum of 2 quarters · filed 2020-11-03 | -$2.21M 10-Q · filed 2020-11-03 | $688.00K derived: sum of 4 quarters · filed 2021-02-23 | |||
| 2019-06-30 | -$2.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | -$7.35M 10-Q · filed 2020-08-04 | -$4.45M derived: sum of 3 quarters · filed 2021-02-23 | -$2.67M derived: sum of 4 quarters · filed 2021-02-23 | |||
| 2019-03-31 | -$4.96M 10-Q · filed 2020-05-04 | -$2.06M derived: sum of 2 quarters · filed 2021-02-23 | -$282.00K derived: sum of 3 quarters · filed 2021-02-23 | $2.47M derived: sum of 4 quarters · filed 2021-02-23 | |||
| 2018-12-31 | $2.90M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $4.67M derived: sum of 2 quarters · filed 2021-02-23 | $7.43M derived: sum of 3 quarters · filed 2021-02-23 | $5.04M 10-K · filed 2021-02-23 | |||
| 2018-09-30 | $1.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $4.53M derived: sum of 2 quarters · filed 2019-11-07 | $2.15M 10-Q · filed 2019-11-07 | $3.40M derived: sum of 4 quarters · filed 2020-02-24 | |||
| 2018-06-30 | $2.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $370.00K 10-Q · filed 2019-08-01 | $1.62M derived: sum of 3 quarters · filed 2020-02-24 | $5.64M derived: sum of 4 quarters · filed 2020-02-24 | |||
| 2018-03-31 | -$2.38M 10-Q · filed 2019-05-09 | -$1.14M derived: sum of 2 quarters · filed 2020-02-24 | $2.89M derived: sum of 3 quarters · filed 2020-02-24 | $5.18M derived: sum of 4 quarters · filed 2020-02-24 | |||
| 2017-12-31 | $1.25M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $5.27M derived: sum of 2 quarters · filed 2020-02-24 | $7.56M derived: sum of 3 quarters · filed 2020-02-24 | $8.55M 10-K · filed 2020-02-24 | |||
| 2017-09-30 | $4.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-02 | $6.31M derived: sum of 2 quarters · filed 2018-11-02 | $7.30M 10-Q · filed 2018-11-02 | $9.38M derived: sum of 4 quarters · filed 2019-02-26 | |||
| 2017-06-30 | $2.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $3.27M 10-Q · filed 2018-08-09 | $5.35M derived: sum of 3 quarters · filed 2019-02-26 | $6.39M derived: sum of 4 quarters · filed 2019-02-26 | |||
| 2017-03-31 | $985.00K 10-Q · filed 2018-05-09 | $3.06M derived: sum of 2 quarters · filed 2019-02-26 | $4.11M derived: sum of 3 quarters · filed 2019-02-26 | $5.41M derived: sum of 4 quarters · filed 2019-02-26 | |||
| 2016-12-31 | $2.08M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $3.12M derived: sum of 2 quarters · filed 2019-02-26 | $4.43M derived: sum of 3 quarters · filed 2019-02-26 | $5.70M 10-K · filed 2019-02-26 | |||
| 2016-09-30 | $1.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03 | $2.35M derived: sum of 2 quarters · filed 2017-11-03 | $3.62M 10-Q · filed 2017-11-03 | $4.04M derived: sum of 4 quarters · filed 2018-02-28 | |||
| 2016-06-30 | $1.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | $2.58M 10-Q · filed 2017-08-02 | $3.00M derived: sum of 3 quarters · filed 2018-02-28 | $3.33M derived: sum of 4 quarters · filed 2018-02-28 | |||
| 2016-03-31 | $1.27M 10-Q · filed 2017-05-02 | $1.70M derived: sum of 2 quarters · filed 2018-02-28 | $2.02M derived: sum of 3 quarters · filed 2018-02-28 | $2.11M derived: sum of 4 quarters · filed 2018-02-28 | |||
| 2015-12-31 | $425.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $750.00K derived: sum of 2 quarters · filed 2018-02-28 | $838.00K derived: sum of 3 quarters · filed 2018-02-28 | $1.38M 10-K · filed 2018-02-28 | |||
| 2015-09-30 | $325.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | $413.00K derived: sum of 2 quarters · filed 2016-11-02 | $956.00K 10-Q · filed 2016-11-02 | ||||
| 2015-06-30 | $88.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | $631.00K 10-Q · filed 2016-08-03 | |||||
| 2015-03-31 | $543.00K 10-Q · filed 2016-05-04 | ||||||
| 2014-12-31 | $575.00K 10-K · filed 2017-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |